GIP/GLP-1 Dual Agonist
Tirzepatide is a synthetic dual agonist targeting both GIP and GLP-1 receptors. It is used in laboratory research to explore combined incretin signaling and comparative receptor pharmacology.
39-residue synthetic dual agonist with C20 diacid
Research use only. Tirzepatide is supplied strictly for in-vitro laboratory and research purposes. It is not a drug or dietary supplement and is not intended for human or veterinary use, diagnosis, or consumption of any kind.